- About Us
- Nano-Social Network
- Nano Consulting
- My Account
March 15th, 2005
The company – Dimerix Bioscience Pty Ltd ("Dimerix") – is a specialist drug development company established to commercialise unique technology developed at the Western Australian Institute for Medical Research in the exciting new field of receptor coupling, specifically G-Protein coupled receptors (“GPCRs”).
Receptor coupling is one of the basic signalling mechanisms of biological systems, and because of their size Starpharma’s nano-structures have natural advantages in designing drugs to control receptor coupling and cell signalling.
|Related News Press|
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Harris & Harris Group Announces a Proposed Strategic Restructuring December 20th, 2016
In-cell molecular sieve from protein crystal February 14th, 2017
Cedars-Sinai, UCLA Scientists Use New ‘Blood Biopsies’ With Experimental Device to Speed Cancer Diagnosis and Predict Disease Spread: Leading-Edge Research Is Part of National Cancer Moonshot Initiative February 13th, 2017
Particles from outer space are wreaking low-grade havoc on personal electronics February 19th, 2017
Engineers shrink microscope to dime-sized device February 17th, 2017